SlideShare una empresa de Scribd logo
1 de 35
CONCEPTS OF RISK
CONCEPTS OF RISK
• Risk is the likelihood or the probability of experiencing some
type of harm, or losing something that one values.
• Risk factors are variables or characteristics (biological -
genetic disorder/ageing, environmental-air/water pollution/
passive smokingor psychosocial- workload/deadlines)
associated with an individual that make it more likely that he
or she, as opposed to another person randomly selected from
the population, will develop a problem.
RISK FACTORS:
• Exists before a disorder or problem;
• Maybe time – limited or may continue over time;
• Can derive from the individual, the family, the community,
institutions or the general environment; and
• Can play a causal role or be a marker for a problem (BRAC)
CHARACTERISTICS OF RISKS:
1. Risk is not certain.
• Risk is based on probability. Therefore, not everyone who is
exposed to a risk condition or factor will have an adverse
outcome. Risk factors are “linked to” and “associated with”
negative outcomes.
• E.g. psychosocial outcomes v/s biological outcomes
• Teratogenic drug – thalidomide, environmental toxin – lead
2.Risk is a relative concept.
• Risk factors range from those that are only markers to
minimally harmful situations to those that are markers to life –
threatening situations.
• (Social continuum of risk/personal risk continuum)
• Risk is not a neutral concept. It involves determining what are
acceptable or unacceptable consequences.
• Risk factors work together over time to influence the
likelihood of a negative outcome.
• The longer the exposure to risk factors, the greater the
likelihood the health problem will occur.
• Risk Identification – Exist as a social context. The
identification of risk will be partially based upon their values,
biases, experience and knowledge.
RISK PURSUED AS
OPPORTUNITY
RELUCTANTLY
ASSUMED RISK
RISK FOR WHICH
NO CHOICE
FREELY ACCEPTED
RISK
Personal risk continuum.
Flow of Risk in Epidemiology:
TRUE RISK
PHARMACOEPIDEMIOLOGICAL
CONSIDERATIONS
(Bias, confounding etc)
STATISTICAL CONSIDERATIONS
(Sampling, models, etc)
MEASURED
ESTIMATED RISK
Risk in Pharmacoepidemiology:
• Health research involves the estimation of risk.
• In the case of drug related research, it is important to
understand the concept of risk.
• It is the probability of developing an outcome when exposed to
a drug.
• A drug is approved for human use only after measuring the
risks and benefits associated with it.
• HCP/Pharmacists should know the magnitude and frequency
of the risk involved in the drug in use.
• Each drug outcome has its own risk.
• It is a probability and depends on a variety of factors like age,
sex, physical conditions, food habits, other diseases, other
medicines, kinetics of drugs etc.
MEASUREMENT OF RISK
 To accurately and precisely measure risk, one needs a tool that
is accurate and precise enough for the measurement being
made.
 Measuring risk in epidemiology , precision and accuracy
depend on factors :
 Degree to which the experimental data and analysis are
free of the errors associated with experimental design
flaws(confounding, bias, reliability, measurement error
and misclassification, potential alternate risk factors)
Statistical analysis errors (sampling error,
violations of model assumptions, model
shopping, multiple subgroup analyses, reliance on
significance levels or p-values.
ATTRIBUTABLE RISK
 Attributable risk is the difference in rate of a condition
between an exposed population and an unexposed population.
 Mostly calculated in Cohort Studies, where individuals are
assembled on exposure status and followed over a period of
time.
 Investigators count the occurrence of the diseases.
 The Cohort is then subdivided by the level of exposure and the
frequency of disease is compared between subgroups.
 One is considered exposed and another unexposed.
AR = Rexposed - Rnon-exposed
where R is the rate of the outcome of the interest or the
Incidence.
Attributable Risk = Incidence in exposed – Incidence in unexposed
%AR = 100 × Rexposed – Rnon-exposed
Rexposed
 The risk of a drug has to be assessed within the environment or
atmosphere where it is used.
 Example : we cannot attribute all incidence of GI discomfort in
people taking Ampicillin capsules to the drug since some may
have it for other reasons than the drug use.
 If the risk due to other reasons than the drug are reduced from the
overall risks, we get attributable risk.
AR = Rexposed - Rnon-exposed
 Attributable risk is also known as risk difference or rate
difference.
 In clinical outcomes the rate difference quantifies one rate in
comparison with another.
 If amoxicillin is 90% successful in treating a specific type of
infection and ampicillin is 65% successful in treating the same
infection, the rate difference 90% -65% = 25%.
RELATIVE RISK
 Relative risk or risk ratio (RR) is the ratio of the probability of
an event occurring ( eg:developing of an ADR to a drug) in an
exposed group to the probability of the event occurring in non-
exposed group.
 Includes 2 features:
i. A comparison of risk between two “exposure” puts
risks in context , and
ii. “exposure” is ensured by having proper denominators
for each group representing the exposure
 RR = Prevent when exposed
Prevent when non-exposed
 It is a ratio of two risks, the risk of the outcome/event in the
treated group compared with the outcome in those not
exposed(control group).
 RR = Proportion of events in experimental group/proportion of
events in control group.
 RR above 1 indicates treatment/exposure is associated with the
outcome and below 1 means that the treatment is negatively
associated with the outcome.
 When the rate in the exposed group is equal to the rate in the
comparison group RR will be equal to 1.
 An RR of 2 means that the rate in the exposed group is twice
that in the non-exposed group.
 An RR of 0.5 means that the rate in the exposed persons is half
that of non-exposed persons.
 Eg: The probability of developing allergy among users of
perfume was 20% and among those not using perfume 1%
Here , a=20, b=80, c=1, d=99
Then the relative risk of allergy associated with users of perfume would be
RR= a/(a+b)
c/(c+d)
= 20/100 = 20
1/100
RISK ALLERGY STATUS
Present Absent
Perfume users a b
Perfume Non- users c d
Different types of RR
 The RR is derived from study designs where the study
population is selected on the basis of exposure (eg: cohort
study),or disease (eg: case- control design) and may have
different names depending on the context :
• In a cohort mortality study the RR is called a standardized
mortality ratio (SMR).
• In a cohort incidence study the RR is called a standardized
incidence ratio (SIR).
• In a morbidity cohort or cross-sectional study the RR may be
called a prevalence ratio.
• In a case-control study the RR is called an odds ratio (OR).
ODDS RATIO:
• It is a measure of association between an exposure and an
outcome like Risk Ratio (RR).
• Odds Ratio in statistics and epidemiology is commonly
abbreviated as ‘OR’.
• Like Risk Ratio determines probabilities, in OR Odds are
used.
• In clinical studies and many other settings, the first parameter
of greatest interest is the RR and the next one is OR.
How to find odds ?
Eg:
There are two sample groups, one consisting of 100 men and
other 100 women were identified from city residential area. In a
dinner party, out of 100 men, 90 drank beer, while out of 100
women only 20 drank beer.
Ans: the odds of a man drinking wine are 90 to 10, or 9:1, while
the odds of a woman drinking wine are 20 to 80, or 1:4=0.25:1.
COMPUTATION OF OR:
• The OR represents the odds that an outcome will occur given a
particular exposure, compared to the odds of the outcome
occurring in the absence of that expoure.
Eg: OR helps to quantify how strongly the presence or absence of
property ‘X’ is associated with the presence or absence of
property ‘Y’ in a given population.
• If each individual in a population either does or does not have
a property “ X” (eg: increased blood sugar level),& also either
does or does not have a property “Y” (eg: use of statins) where
both properties are appropriately defined, then a ratio can be
formed.
• This ratio quantitatively describes the association between the
presence/ absence of “ X” and the presence / absence of “Y”
for individuals in the population. This ratio is the Odds Ratio.
• The OR can be computed by following these steps:
1. For a given individual that has “Y” compute the odds that the
same individual has”X”.
2. For a given individual that does not have “Y” compute the
odds that the same individual has “X”.
3. Divide the odds from step 1 by the odds from step 2 to obtain
the OR.
• The term “individual” in this usage does not have to refer to a
human being , as a statistical population can measure any set
of entities, whether living or inanimate.
• If the OR is greater than 1, then having “X” is considered to be
“associated” with having “Y” in the sense that the having of
“Y” raises ( relative to not having “Y”) the odds of having
“X”.
• Note that this is not enough to establish that ‘Y’ is a
contributing cause of “X”: it could be that the association is
due to a third property , “Z”, which is a contributing cause of
both “X” and “Y”.
• Illustration 1:
Take the same illustration given for finding odds above. Now
we can find the OR as shown below
The OR is 9/0.25, or 36. It shows that men are much more
likely to drink wine than women.
The detailed calculation is :
0.9/0.1 = 0.9 ×0.8 = 0.72 = 36
0.2/0.8 0.1 × 0.2 0.02
This eg also shows how odds ratios are sometimes sensitive in
stating relative positions. In this illustration men are 90/20 = 4.5
times as likely to have drunk beer than women, but have 36 times
the odds.
• Illustration 2: odds ratio contingency
OR = a/c = a×d
b/d b×c
Cases Control Total
Exposed a b a+b
Unexposed c d c+d
Total a+c b+d (a+b) + (c+d)
• Imagine a group of 20 students went out to the pub – the next
day a 7 were ill. They suspect that it may have been something
they ate, may be the fish casserole. Here are the numbers:
Cases (illness) Control (no
illness)
Total
Exposed (ate
fish)
5 3 8
Unexposed
(didn’t eat fish)
2 10 12
Total 7 13 20
• Odds of exposure in cases = a/c = 5/2 = 2.5
• Odds of exposure in controls = b/d = 3/10 = 0.3
• Odds Ratio = (a/c) / (b/d) = 2.5/0.3 = 8.33
INTERPRETATION: WHAT DOES THIS MEAN ?
• OR of 1 would suggest that there is no difference between the
groups; i.e., there would be no association between the
suggested exposure (fish) and the outcome being ill.
• OR of > 1 suggests that the odds of exposure are positively
associated with the adverse outcome compared to the odds of
not being exposed.
• OR of < 1 suggests that the odds of exposure are negatively
associated with the adverse outcomes compared to the odds of
not being exposed.
• In the eg above, we can conclude that those who ate the fish
casserole (exposure) were 8.3 times more likely (OR = 8.3) to
be ill (outcome), compared to those who did not eat the fish
casserole.
ADVANTAGES:
• Appropriate to analyse associations between groups from case-
control and prevalent (or cross-sectional) data.
• For rare diseases (or diseases with long latency periods) the
OR can be an approximate measure to the RR .
• Doesn’t require denominator (i.e. total number in population)
unlike measuring risk.
• Good method to estimate the strength of an association
between exposures and outcome.
DISADVANTAGES:
• Association does not infer causation.
TIME RISK RELATIONSHIP:
• The outcome of an exposure to a drug is related to
the time.
• It is also true with risks associated with medicines.
• There is always a time related association of risk in
pharmacoepidemiology.
• Certain events like anaphylactic reactions happen
immediately after taking an injection while certain
other risk events occur after days or months or even
years.
.
• Eg: prazosin , an alpha blocker has main effect in dilation of
veins and arteries which leads to reduction in BP. It is
sometimes also used for BPH. To minimize the impact of first
dose effect, prazosin is normally taken at bedtime. Other drugs
of same family, doxazosin and terazosin, can also cause this
phenomenon, though less frequently
• Delayed reactions to medications commonly begin more than
6 hrs after exposure but sometimes occur days after exposure.
Eg: delayed ADR to amoxicillin classically start between 7 to 10
days of exposure and may even begin 1 to 3 days after the
patients had stopped taking the medicine.
• Medications that cause delayed reactions include heparin, quinine,
sulphonamides, vancomycin, gold compounds, beta lactam antibiotics and
NSAIDs.
• Lomustine is an anticancer drug used in different types of cancer which has
an adverse effect of producing leucopenia that occurs 6 weeks after the
dose.
• The above mentioned aspects of medicine demonstrate that the exposure
time must always be considered and the risk should be expressed as a
function of time wherever possible in pharmacoepidemiology.
CONFIDENCE INTERVAL (CI):
• CI are a range of values within which the true population values probably
lies .
• When the risk estimators like RR or OR are calculated they are presented
with a CI.
• Generally a 95% CI (CI95) is calculated which means that we are 95%
confident that the true value lies between these limits.
ABSOLUTE RISK:
• The risk of having a disease at any point in time is known as
Absolute Risk.
• It is the incidence.
• If the incidence of epilepsy is 1 in 10,0000 then the absolute
risk is 0.001 %.
EXPERIMENTAL EVENT RATE (EER):
• It is the proportion of patients in the treated group in whom an
event is observed.
• If out of 100 treated patients (a+b), the event is observed in 27
(a), the EER = 0.27, that is
EER = [a/(a+b)]
CONTROL EVENT RATE (CER):
• It is the proportion of patients in the control group in whom
an event is observed.
CER = c/(c+d)
THANK YOU

Más contenido relacionado

La actualidad más candente

Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Dr.Sohel Memon
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATION
aishuanju
 
Analysis of pk data- Pop PK analysis
Analysis of pk data- Pop PK analysisAnalysis of pk data- Pop PK analysis
Analysis of pk data- Pop PK analysis
Gayathri Ravi
 

La actualidad más candente (20)

Concept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology PresentationConcept of risk in pharmacoepidemiology Presentation
Concept of risk in pharmacoepidemiology Presentation
 
Markov model
Markov modelMarkov model
Markov model
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Pharmacoepidemiology and risk management
Pharmacoepidemiology and risk management Pharmacoepidemiology and risk management
Pharmacoepidemiology and risk management
 
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
Studies of vaccine safety (Pharmacoepidemiology)  V PharmDStudies of vaccine safety (Pharmacoepidemiology)  V PharmD
Studies of vaccine safety (Pharmacoepidemiology) V PharmD
 
Measuring of risk
Measuring of riskMeasuring of risk
Measuring of risk
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
 
Prescription Event Monitoring & Record Linkage Systems
Prescription Event Monitoring & Record Linkage SystemsPrescription Event Monitoring & Record Linkage Systems
Prescription Event Monitoring & Record Linkage Systems
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology Definition and scope of Pharmacoepidemiology
Definition and scope of Pharmacoepidemiology
 
Cost Utility Analysis
Cost Utility AnalysisCost Utility Analysis
Cost Utility Analysis
 
Drug induced birth defect
Drug induced birth defectDrug induced birth defect
Drug induced birth defect
 
DRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATIONDRUG UTILIZATION EVALUATION
DRUG UTILIZATION EVALUATION
 
Unit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiologyUnit 1 pharmacoepidemiology
Unit 1 pharmacoepidemiology
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
Analysis of pk data- Pop PK analysis
Analysis of pk data- Pop PK analysisAnalysis of pk data- Pop PK analysis
Analysis of pk data- Pop PK analysis
 
Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology Hospital Pharmaco-epidemiology
Hospital Pharmaco-epidemiology
 
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN.pptx
NOMOGRAMS AND TABULATIONS IN   DESIGNING DOSAGE REGIMEN.pptxNOMOGRAMS AND TABULATIONS IN   DESIGNING DOSAGE REGIMEN.pptx
NOMOGRAMS AND TABULATIONS IN DESIGNING DOSAGE REGIMEN.pptx
 
Cost utility analysis
Cost utility analysisCost utility analysis
Cost utility analysis
 

Similar a concept of risk

Common measures and statistics in epidemiological literature
Common measures and statistics in epidemiological literatureCommon measures and statistics in epidemiological literature
Common measures and statistics in epidemiological literature
Kadium
 
You have just finished a health education in-service to the communit.docx
You have just finished a health education in-service to the communit.docxYou have just finished a health education in-service to the communit.docx
You have just finished a health education in-service to the communit.docx
briancrawford30935
 
Analytic StudiesThere are basically two types of studies experi.docx
Analytic StudiesThere are basically two types of studies experi.docxAnalytic StudiesThere are basically two types of studies experi.docx
Analytic StudiesThere are basically two types of studies experi.docx
rossskuddershamus
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort study
Bhumika Bhatt
 
MEASURES OF ASSOCIATION.docx
MEASURES OF ASSOCIATION.docxMEASURES OF ASSOCIATION.docx
MEASURES OF ASSOCIATION.docx
kihembopamelah
 
Excelsior College PBH 321 Page 1 CASE-CONTROL STU.docx
Excelsior College PBH 321    Page 1 CASE-CONTROL STU.docxExcelsior College PBH 321    Page 1 CASE-CONTROL STU.docx
Excelsior College PBH 321 Page 1 CASE-CONTROL STU.docx
gitagrimston
 

Similar a concept of risk (20)

Estimating risk ,pptx
Estimating risk ,pptxEstimating risk ,pptx
Estimating risk ,pptx
 
Case-control study un.uob.pptx
Case-control study un.uob.pptxCase-control study un.uob.pptx
Case-control study un.uob.pptx
 
Risk Comparison
Risk ComparisonRisk Comparison
Risk Comparison
 
Lecture measure of effect and disase causation
Lecture measure of effect and disase causationLecture measure of effect and disase causation
Lecture measure of effect and disase causation
 
Common measures and statistics in epidemiological literature
Common measures and statistics in epidemiological literatureCommon measures and statistics in epidemiological literature
Common measures and statistics in epidemiological literature
 
You have just finished a health education in-service to the communit.docx
You have just finished a health education in-service to the communit.docxYou have just finished a health education in-service to the communit.docx
You have just finished a health education in-service to the communit.docx
 
Analytic StudiesThere are basically two types of studies experi.docx
Analytic StudiesThere are basically two types of studies experi.docxAnalytic StudiesThere are basically two types of studies experi.docx
Analytic StudiesThere are basically two types of studies experi.docx
 
Risk assessment
Risk assessmentRisk assessment
Risk assessment
 
Alok Kumar (Grp 09) Measures Of Association.pptx
Alok Kumar (Grp 09) Measures Of Association.pptxAlok Kumar (Grp 09) Measures Of Association.pptx
Alok Kumar (Grp 09) Measures Of Association.pptx
 
Case control & cohort study
Case control & cohort studyCase control & cohort study
Case control & cohort study
 
Epidemiology Depuk sir_ 1,2,3 chapter,OK
Epidemiology Depuk sir_ 1,2,3 chapter,OKEpidemiology Depuk sir_ 1,2,3 chapter,OK
Epidemiology Depuk sir_ 1,2,3 chapter,OK
 
Estimating risk
Estimating riskEstimating risk
Estimating risk
 
Cohort study design.ppt Epidemiology medical
Cohort study design.ppt Epidemiology medicalCohort study design.ppt Epidemiology medical
Cohort study design.ppt Epidemiology medical
 
10-Interpretation& Causality by Mehdi Ehtesham
10-Interpretation& Causality  by Mehdi Ehtesham10-Interpretation& Causality  by Mehdi Ehtesham
10-Interpretation& Causality by Mehdi Ehtesham
 
Epidemiology, risk,rate,ratio,odd ratio
Epidemiology, risk,rate,ratio,odd ratioEpidemiology, risk,rate,ratio,odd ratio
Epidemiology, risk,rate,ratio,odd ratio
 
MEASURES OF ASSOCIATION.docx
MEASURES OF ASSOCIATION.docxMEASURES OF ASSOCIATION.docx
MEASURES OF ASSOCIATION.docx
 
Case control study
Case control studyCase control study
Case control study
 
2014 lab slides_mo_a
2014 lab slides_mo_a2014 lab slides_mo_a
2014 lab slides_mo_a
 
Risk assessment.doc
Risk assessment.docRisk assessment.doc
Risk assessment.doc
 
Excelsior College PBH 321 Page 1 CASE-CONTROL STU.docx
Excelsior College PBH 321    Page 1 CASE-CONTROL STU.docxExcelsior College PBH 321    Page 1 CASE-CONTROL STU.docx
Excelsior College PBH 321 Page 1 CASE-CONTROL STU.docx
 

Más de aiswarya thomas

Más de aiswarya thomas (6)

Mechanism of pathogenicity-Exotoxin and endotoxin
Mechanism of pathogenicity-Exotoxin and endotoxinMechanism of pathogenicity-Exotoxin and endotoxin
Mechanism of pathogenicity-Exotoxin and endotoxin
 
Investigational New Drug Application
Investigational New Drug ApplicationInvestigational New Drug Application
Investigational New Drug Application
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
 
Post marketing surveilance
Post marketing surveilancePost marketing surveilance
Post marketing surveilance
 
drug discovery- clinical development
drug discovery- clinical developmentdrug discovery- clinical development
drug discovery- clinical development
 
drug discovery- history, evolution and stages
drug discovery- history, evolution and stagesdrug discovery- history, evolution and stages
drug discovery- history, evolution and stages
 

Último

Russian Call Girls In Pune 👉 Just CALL ME: 9352988975 ✅❤️💯low cost unlimited ...
Russian Call Girls In Pune 👉 Just CALL ME: 9352988975 ✅❤️💯low cost unlimited ...Russian Call Girls In Pune 👉 Just CALL ME: 9352988975 ✅❤️💯low cost unlimited ...
Russian Call Girls In Pune 👉 Just CALL ME: 9352988975 ✅❤️💯low cost unlimited ...
chanderprakash5506
 
Call Girl in Chennai | Whatsapp No 📞 7427069034 📞 VIP Escorts Service Availab...
Call Girl in Chennai | Whatsapp No 📞 7427069034 📞 VIP Escorts Service Availab...Call Girl in Chennai | Whatsapp No 📞 7427069034 📞 VIP Escorts Service Availab...
Call Girl in Chennai | Whatsapp No 📞 7427069034 📞 VIP Escorts Service Availab...
amritaverma53
 
❤️ Chandigarh Call Girls☎️98151-579OO☎️ Call Girl service in Chandigarh ☎️ Ch...
❤️ Chandigarh Call Girls☎️98151-579OO☎️ Call Girl service in Chandigarh ☎️ Ch...❤️ Chandigarh Call Girls☎️98151-579OO☎️ Call Girl service in Chandigarh ☎️ Ch...
❤️ Chandigarh Call Girls☎️98151-579OO☎️ Call Girl service in Chandigarh ☎️ Ch...
Rashmi Entertainment
 
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
rajnisinghkjn
 

Último (20)

Russian Call Girls In Pune 👉 Just CALL ME: 9352988975 ✅❤️💯low cost unlimited ...
Russian Call Girls In Pune 👉 Just CALL ME: 9352988975 ✅❤️💯low cost unlimited ...Russian Call Girls In Pune 👉 Just CALL ME: 9352988975 ✅❤️💯low cost unlimited ...
Russian Call Girls In Pune 👉 Just CALL ME: 9352988975 ✅❤️💯low cost unlimited ...
 
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book nowChennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
 
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room DeliveryCall 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
 
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
Race Course Road } Book Call Girls in Bangalore | Whatsapp No 6378878445 VIP ...
 
Call Girl in Chennai | Whatsapp No 📞 7427069034 📞 VIP Escorts Service Availab...
Call Girl in Chennai | Whatsapp No 📞 7427069034 📞 VIP Escorts Service Availab...Call Girl in Chennai | Whatsapp No 📞 7427069034 📞 VIP Escorts Service Availab...
Call Girl in Chennai | Whatsapp No 📞 7427069034 📞 VIP Escorts Service Availab...
 
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableCall Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
 
Call Girls Wayanad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Wayanad Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Wayanad Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Wayanad Just Call 8250077686 Top Class Call Girl Service Available
 
Call girls Service Phullen / 9332606886 Genuine Call girls with real Photos a...
Call girls Service Phullen / 9332606886 Genuine Call girls with real Photos a...Call girls Service Phullen / 9332606886 Genuine Call girls with real Photos a...
Call girls Service Phullen / 9332606886 Genuine Call girls with real Photos a...
 
Call Girls Bangalore - 450+ Call Girl Cash Payment 💯Call Us 🔝 6378878445 🔝 💃 ...
Call Girls Bangalore - 450+ Call Girl Cash Payment 💯Call Us 🔝 6378878445 🔝 💃 ...Call Girls Bangalore - 450+ Call Girl Cash Payment 💯Call Us 🔝 6378878445 🔝 💃 ...
Call Girls Bangalore - 450+ Call Girl Cash Payment 💯Call Us 🔝 6378878445 🔝 💃 ...
 
❤️ Chandigarh Call Girls☎️98151-579OO☎️ Call Girl service in Chandigarh ☎️ Ch...
❤️ Chandigarh Call Girls☎️98151-579OO☎️ Call Girl service in Chandigarh ☎️ Ch...❤️ Chandigarh Call Girls☎️98151-579OO☎️ Call Girl service in Chandigarh ☎️ Ch...
❤️ Chandigarh Call Girls☎️98151-579OO☎️ Call Girl service in Chandigarh ☎️ Ch...
 
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
Bhawanipatna Call Girls 📞9332606886 Call Girls in Bhawanipatna Escorts servic...
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
 
Circulatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanismsCirculatory Shock, types and stages, compensatory mechanisms
Circulatory Shock, types and stages, compensatory mechanisms
 
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
 
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
 
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
 
Lucknow Call Girls Just Call 👉👉8630512678 Top Class Call Girl Service Available
Lucknow Call Girls Just Call 👉👉8630512678 Top Class Call Girl Service AvailableLucknow Call Girls Just Call 👉👉8630512678 Top Class Call Girl Service Available
Lucknow Call Girls Just Call 👉👉8630512678 Top Class Call Girl Service Available
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their Regulation
 
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 9667172968 Top Class Call Girl Service Available
 
💞 Safe And Secure Call Girls Coimbatore🧿 6378878445 🧿 High Class Coimbatore C...
💞 Safe And Secure Call Girls Coimbatore🧿 6378878445 🧿 High Class Coimbatore C...💞 Safe And Secure Call Girls Coimbatore🧿 6378878445 🧿 High Class Coimbatore C...
💞 Safe And Secure Call Girls Coimbatore🧿 6378878445 🧿 High Class Coimbatore C...
 

concept of risk

  • 2. CONCEPTS OF RISK • Risk is the likelihood or the probability of experiencing some type of harm, or losing something that one values. • Risk factors are variables or characteristics (biological - genetic disorder/ageing, environmental-air/water pollution/ passive smokingor psychosocial- workload/deadlines) associated with an individual that make it more likely that he or she, as opposed to another person randomly selected from the population, will develop a problem.
  • 3. RISK FACTORS: • Exists before a disorder or problem; • Maybe time – limited or may continue over time; • Can derive from the individual, the family, the community, institutions or the general environment; and • Can play a causal role or be a marker for a problem (BRAC) CHARACTERISTICS OF RISKS: 1. Risk is not certain. • Risk is based on probability. Therefore, not everyone who is exposed to a risk condition or factor will have an adverse outcome. Risk factors are “linked to” and “associated with” negative outcomes. • E.g. psychosocial outcomes v/s biological outcomes • Teratogenic drug – thalidomide, environmental toxin – lead
  • 4. 2.Risk is a relative concept. • Risk factors range from those that are only markers to minimally harmful situations to those that are markers to life – threatening situations. • (Social continuum of risk/personal risk continuum) • Risk is not a neutral concept. It involves determining what are acceptable or unacceptable consequences. • Risk factors work together over time to influence the likelihood of a negative outcome. • The longer the exposure to risk factors, the greater the likelihood the health problem will occur. • Risk Identification – Exist as a social context. The identification of risk will be partially based upon their values, biases, experience and knowledge.
  • 5. RISK PURSUED AS OPPORTUNITY RELUCTANTLY ASSUMED RISK RISK FOR WHICH NO CHOICE FREELY ACCEPTED RISK Personal risk continuum.
  • 6. Flow of Risk in Epidemiology: TRUE RISK PHARMACOEPIDEMIOLOGICAL CONSIDERATIONS (Bias, confounding etc) STATISTICAL CONSIDERATIONS (Sampling, models, etc) MEASURED ESTIMATED RISK
  • 7. Risk in Pharmacoepidemiology: • Health research involves the estimation of risk. • In the case of drug related research, it is important to understand the concept of risk. • It is the probability of developing an outcome when exposed to a drug. • A drug is approved for human use only after measuring the risks and benefits associated with it. • HCP/Pharmacists should know the magnitude and frequency of the risk involved in the drug in use. • Each drug outcome has its own risk. • It is a probability and depends on a variety of factors like age, sex, physical conditions, food habits, other diseases, other medicines, kinetics of drugs etc.
  • 8. MEASUREMENT OF RISK  To accurately and precisely measure risk, one needs a tool that is accurate and precise enough for the measurement being made.  Measuring risk in epidemiology , precision and accuracy depend on factors :  Degree to which the experimental data and analysis are free of the errors associated with experimental design flaws(confounding, bias, reliability, measurement error and misclassification, potential alternate risk factors)
  • 9. Statistical analysis errors (sampling error, violations of model assumptions, model shopping, multiple subgroup analyses, reliance on significance levels or p-values.
  • 10. ATTRIBUTABLE RISK  Attributable risk is the difference in rate of a condition between an exposed population and an unexposed population.  Mostly calculated in Cohort Studies, where individuals are assembled on exposure status and followed over a period of time.  Investigators count the occurrence of the diseases.  The Cohort is then subdivided by the level of exposure and the frequency of disease is compared between subgroups.
  • 11.  One is considered exposed and another unexposed. AR = Rexposed - Rnon-exposed where R is the rate of the outcome of the interest or the Incidence. Attributable Risk = Incidence in exposed – Incidence in unexposed %AR = 100 × Rexposed – Rnon-exposed Rexposed
  • 12.  The risk of a drug has to be assessed within the environment or atmosphere where it is used.  Example : we cannot attribute all incidence of GI discomfort in people taking Ampicillin capsules to the drug since some may have it for other reasons than the drug use.  If the risk due to other reasons than the drug are reduced from the overall risks, we get attributable risk. AR = Rexposed - Rnon-exposed  Attributable risk is also known as risk difference or rate difference.
  • 13.  In clinical outcomes the rate difference quantifies one rate in comparison with another.  If amoxicillin is 90% successful in treating a specific type of infection and ampicillin is 65% successful in treating the same infection, the rate difference 90% -65% = 25%.
  • 14. RELATIVE RISK  Relative risk or risk ratio (RR) is the ratio of the probability of an event occurring ( eg:developing of an ADR to a drug) in an exposed group to the probability of the event occurring in non- exposed group.  Includes 2 features: i. A comparison of risk between two “exposure” puts risks in context , and ii. “exposure” is ensured by having proper denominators for each group representing the exposure
  • 15.  RR = Prevent when exposed Prevent when non-exposed  It is a ratio of two risks, the risk of the outcome/event in the treated group compared with the outcome in those not exposed(control group).  RR = Proportion of events in experimental group/proportion of events in control group.  RR above 1 indicates treatment/exposure is associated with the outcome and below 1 means that the treatment is negatively associated with the outcome.
  • 16.  When the rate in the exposed group is equal to the rate in the comparison group RR will be equal to 1.  An RR of 2 means that the rate in the exposed group is twice that in the non-exposed group.  An RR of 0.5 means that the rate in the exposed persons is half that of non-exposed persons.  Eg: The probability of developing allergy among users of perfume was 20% and among those not using perfume 1%
  • 17. Here , a=20, b=80, c=1, d=99 Then the relative risk of allergy associated with users of perfume would be RR= a/(a+b) c/(c+d) = 20/100 = 20 1/100 RISK ALLERGY STATUS Present Absent Perfume users a b Perfume Non- users c d
  • 18. Different types of RR  The RR is derived from study designs where the study population is selected on the basis of exposure (eg: cohort study),or disease (eg: case- control design) and may have different names depending on the context : • In a cohort mortality study the RR is called a standardized mortality ratio (SMR). • In a cohort incidence study the RR is called a standardized incidence ratio (SIR). • In a morbidity cohort or cross-sectional study the RR may be called a prevalence ratio. • In a case-control study the RR is called an odds ratio (OR).
  • 19. ODDS RATIO: • It is a measure of association between an exposure and an outcome like Risk Ratio (RR). • Odds Ratio in statistics and epidemiology is commonly abbreviated as ‘OR’. • Like Risk Ratio determines probabilities, in OR Odds are used. • In clinical studies and many other settings, the first parameter of greatest interest is the RR and the next one is OR.
  • 20. How to find odds ? Eg: There are two sample groups, one consisting of 100 men and other 100 women were identified from city residential area. In a dinner party, out of 100 men, 90 drank beer, while out of 100 women only 20 drank beer. Ans: the odds of a man drinking wine are 90 to 10, or 9:1, while the odds of a woman drinking wine are 20 to 80, or 1:4=0.25:1.
  • 21. COMPUTATION OF OR: • The OR represents the odds that an outcome will occur given a particular exposure, compared to the odds of the outcome occurring in the absence of that expoure. Eg: OR helps to quantify how strongly the presence or absence of property ‘X’ is associated with the presence or absence of property ‘Y’ in a given population. • If each individual in a population either does or does not have a property “ X” (eg: increased blood sugar level),& also either does or does not have a property “Y” (eg: use of statins) where both properties are appropriately defined, then a ratio can be formed.
  • 22. • This ratio quantitatively describes the association between the presence/ absence of “ X” and the presence / absence of “Y” for individuals in the population. This ratio is the Odds Ratio. • The OR can be computed by following these steps: 1. For a given individual that has “Y” compute the odds that the same individual has”X”. 2. For a given individual that does not have “Y” compute the odds that the same individual has “X”. 3. Divide the odds from step 1 by the odds from step 2 to obtain the OR.
  • 23. • The term “individual” in this usage does not have to refer to a human being , as a statistical population can measure any set of entities, whether living or inanimate. • If the OR is greater than 1, then having “X” is considered to be “associated” with having “Y” in the sense that the having of “Y” raises ( relative to not having “Y”) the odds of having “X”. • Note that this is not enough to establish that ‘Y’ is a contributing cause of “X”: it could be that the association is due to a third property , “Z”, which is a contributing cause of both “X” and “Y”.
  • 24. • Illustration 1: Take the same illustration given for finding odds above. Now we can find the OR as shown below The OR is 9/0.25, or 36. It shows that men are much more likely to drink wine than women. The detailed calculation is : 0.9/0.1 = 0.9 ×0.8 = 0.72 = 36 0.2/0.8 0.1 × 0.2 0.02 This eg also shows how odds ratios are sometimes sensitive in stating relative positions. In this illustration men are 90/20 = 4.5 times as likely to have drunk beer than women, but have 36 times the odds.
  • 25. • Illustration 2: odds ratio contingency OR = a/c = a×d b/d b×c Cases Control Total Exposed a b a+b Unexposed c d c+d Total a+c b+d (a+b) + (c+d)
  • 26. • Imagine a group of 20 students went out to the pub – the next day a 7 were ill. They suspect that it may have been something they ate, may be the fish casserole. Here are the numbers: Cases (illness) Control (no illness) Total Exposed (ate fish) 5 3 8 Unexposed (didn’t eat fish) 2 10 12 Total 7 13 20
  • 27. • Odds of exposure in cases = a/c = 5/2 = 2.5 • Odds of exposure in controls = b/d = 3/10 = 0.3 • Odds Ratio = (a/c) / (b/d) = 2.5/0.3 = 8.33 INTERPRETATION: WHAT DOES THIS MEAN ? • OR of 1 would suggest that there is no difference between the groups; i.e., there would be no association between the suggested exposure (fish) and the outcome being ill. • OR of > 1 suggests that the odds of exposure are positively associated with the adverse outcome compared to the odds of not being exposed. • OR of < 1 suggests that the odds of exposure are negatively associated with the adverse outcomes compared to the odds of not being exposed.
  • 28. • In the eg above, we can conclude that those who ate the fish casserole (exposure) were 8.3 times more likely (OR = 8.3) to be ill (outcome), compared to those who did not eat the fish casserole. ADVANTAGES: • Appropriate to analyse associations between groups from case- control and prevalent (or cross-sectional) data. • For rare diseases (or diseases with long latency periods) the OR can be an approximate measure to the RR .
  • 29. • Doesn’t require denominator (i.e. total number in population) unlike measuring risk. • Good method to estimate the strength of an association between exposures and outcome. DISADVANTAGES: • Association does not infer causation.
  • 30. TIME RISK RELATIONSHIP: • The outcome of an exposure to a drug is related to the time. • It is also true with risks associated with medicines. • There is always a time related association of risk in pharmacoepidemiology. • Certain events like anaphylactic reactions happen immediately after taking an injection while certain other risk events occur after days or months or even years. .
  • 31. • Eg: prazosin , an alpha blocker has main effect in dilation of veins and arteries which leads to reduction in BP. It is sometimes also used for BPH. To minimize the impact of first dose effect, prazosin is normally taken at bedtime. Other drugs of same family, doxazosin and terazosin, can also cause this phenomenon, though less frequently • Delayed reactions to medications commonly begin more than 6 hrs after exposure but sometimes occur days after exposure. Eg: delayed ADR to amoxicillin classically start between 7 to 10 days of exposure and may even begin 1 to 3 days after the patients had stopped taking the medicine.
  • 32. • Medications that cause delayed reactions include heparin, quinine, sulphonamides, vancomycin, gold compounds, beta lactam antibiotics and NSAIDs. • Lomustine is an anticancer drug used in different types of cancer which has an adverse effect of producing leucopenia that occurs 6 weeks after the dose. • The above mentioned aspects of medicine demonstrate that the exposure time must always be considered and the risk should be expressed as a function of time wherever possible in pharmacoepidemiology. CONFIDENCE INTERVAL (CI): • CI are a range of values within which the true population values probably lies . • When the risk estimators like RR or OR are calculated they are presented with a CI. • Generally a 95% CI (CI95) is calculated which means that we are 95% confident that the true value lies between these limits.
  • 33. ABSOLUTE RISK: • The risk of having a disease at any point in time is known as Absolute Risk. • It is the incidence. • If the incidence of epilepsy is 1 in 10,0000 then the absolute risk is 0.001 %. EXPERIMENTAL EVENT RATE (EER): • It is the proportion of patients in the treated group in whom an event is observed. • If out of 100 treated patients (a+b), the event is observed in 27 (a), the EER = 0.27, that is EER = [a/(a+b)]
  • 34. CONTROL EVENT RATE (CER): • It is the proportion of patients in the control group in whom an event is observed. CER = c/(c+d)